Thyroid Cancer Advance Panel

Test Code
SLS163001
Book Now

What is the Thyroid Cancer Advance Panel?

This advanced panel evaluates mutations involved in thyroid cancer in 6 genes using DNA sequencing and fusions in 3 genes using RNA sequencing. By combining DNA and RNA analysis, this panel provides a deeper molecular profile to support both diagnostic clarity and targeted treatment planning.

Genes Covered/ No. of Genes: SNVs, InDels, and CNVs in 6 genes (DNA sequencing); Fusions in 3 genes (RNA sequencing)

Who Is This Test For?

Patients with suspicious thyroid nodules requiring further molecular characterization, or individuals with advanced or aggressive thyroid cancer who are being considered for targeted therapies

Key Features

Combines DNA and RNA analysis

Clinical Applications

  • Detects clinically actionable mutations and gene fusions relevant to targeted therapy selection
  • Supports risk stratification, surgical planning, and diagnostic precision
  • Aids in managing aggressive thyroid cancers that may benefit from personalized treatment approaches

Thyroid Cancer

Contact Us